UPC Analytics
ENDE
Overview · Filed: Sep 12, 2025

UPC_CFI_858/2025

INDOLIDONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

InfringementMain Infringement ActionLisbon LDInfringementWritten Phase
Parties

Claimants

  • Boehringer Ingelheim International GmbH
Reps: Joana Catarina Piriquito Santos (NLP - Nazaré, Lima, Piriquito Santos & Associados); Sara Nazaré (NLP - Nazaré, Lima, Piriquito Santos & Associados); Beatriz Lima (NLP - Nazaré, Lima, Piriquito Santos & Associados)

Respondents

  • ZENTIVA PORTUGAL, LDA
Reps: Patrícia Paias (Antas da Cunha ECIJA); Daniela Guimarães (Antas da Cunha ECIJA)
Judges
  • Rute Lopes
  • Camille Lignieres
  • Petri Rinkinen
Patents
  • EP1830843
  • EP 1 830 843
CPC codes: C07D403/12, A61K31/4178, A61K31/4045, A61K31/496, A61K31/495, A61K47/38, A61K9/08, C07D209/34, A61K9/1623, A61K47/10, A61K31/404, A61K9/0031

Technology area: Pharmaceuticals · Small Molecule

Sector: Organic Chemistry

Outcome
Procedural onlyProcedural only (no substantive ruling yet)
Filed: Sep 12, 2025
First decided: Nov 17, 2025
Language: English
Open on UPC Registry